Sohini Das

Zydus to acquire Assertio in ₹1,570 crore deal to expand US business

Acquisition gives Zydus a branded-drugs commercial platform in the US and strengthens its specialty pharmaceutical presence in pain and oncology therapies

Tata Motors Q4 PAT rises 34% to ₹1,793 cr on strong operational performance

Commercial vehicle maker reports higher volumes, stronger margins and record annual revenue despite headwinds from commodity prices and West Asia tensions

Tata-backed Impetis licenses JAK inhibitor assets to Vyome Holdings

Deal gives Vyome entry into the fast-growing market for next-generation autoimmune and inflammatory disease drugs

Passenger vehicle sales seen hitting record 5.9 mn units in FY27: Crisil

Crisil Ratings expects India's passenger vehicle industry to post record sales this fiscal, supported by GST-led demand recovery and continued preference for utility vehicles

100 years on, Bajaj Group begins to build anew for India's future growth

Bajaj Group's centenary is less a celebration than a pivot into healthcare, electric mobility and the AI age

India joins weight-loss drug race, but affordability remains a concern

India is in the race for a new class of weight-loss drugs, but the question is: Will they be affordable?

'Need to play our part': India Inc backs PM's call, but cautious on WFH

Companies still weighing work from home appeal

Claire has what it takes to lead Biocon forward: Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw explained why she has chosen her niece, Claire, as her successor, outlining a five-year transition plan that will eventually see Claire take over as chairperson

Biocon eyes in-licensing opportunities to expand biosimilars portfolio

Biocon is scouting for biosimilar in-licensing opportunities while banking on multiple FY27 product launches to drive growth, margins, and market expansion

Bajaj to launch new Pulsars across 125-250cc range before festive season

Bajaj Auto plans fresh Pulsar launches across the 125cc-250cc range in Q2 FY27 as premium motorcycle segments continue to outpace overall market growth

Bajaj Auto Q4 profit more than doubles to ₹3,662 crore on record volumes

Bajaj Auto reported strong Q4 FY26 earnings, driven by record volumes, export growth, improved product mix and rising contribution from electric vehicles

M&M strengthens supply-chain resilience as geopolitical risks persist

Mahindra & Mahindra is strengthening localisation, multi-sourcing and platform flexibility to counter geopolitical disruptions and secure growth in its auto business

M&M Q4FY26 results: PAT up 42% on strong momentum across businesses

Mahindra & Mahindra reports a 42% rise in Q4 PAT to Rs 4,668 crore, driven by strong performance in auto, farm and services businesses, alongside steady growth in EVs

Kiran Mazumdar-Shaw names niece Claire Mazumdar as successor at Biocon

Biocon founder Kiran Mazumdar-Shaw outlines a five-year transition plan, naming niece Claire Mazumdar as successor to lead the company's next growth phase

West Bengal election results: Industrialists pin hopes on BJP's win

Strained Centre-state relations had long made investors wary, a sentiment reinforced by Trinamool leader Mamata Banerjee's rise on the back of a land agitation in Singur and Nandigram

Sun Pharma exploring Eurobonds, bond swaps to fund US-based Organon buy

According to bankers, the Indian pharma major plans to raise around $10 billion from various sources, while the remaining will be funded through internal accruals

EV sales jump nearly 70% in Jan-Apr; momentum sustains beyond March spike

April volumes hold near peak despite fewer selling days; Tata leads while M&M and Maruti gain share amid broad-based growth

Drug exports to US fall 10% in FY26 as EU and Africa drive growth

India's pharma exports hit a record in FY26 but growth slowed as US demand weakened; vaccines, bulk drugs and diversification into EU and Africa supported gains

Sun Pharma bets on Organon front-end to drive global growth, efficiencies

Sun Pharma sees its Organon acquisition as a platform to expand globally, boost in-licensing, and improve long-term efficiencies through a stronger commercial front-end

Asia-Oceania emerging auto industry's centre of gravity: Shailesh Chandra

Asia-Oceania leads global vehicle growth and demand, consolidating its role as both manufacturing hub and consumption market, amid uneven recovery across Europe and the Americas